Clinical Trials Browser

Advanced Breast Cancer

NCT06188520 2026-04-08

CYCAD-1

Phase 1/2 Recruiting

564 enrolled

BreastGynecologic

ER+ HER2- Advanced Breast Cancer

NCT05696626 2026-04-07

ELAINEIII

Phase 3 Recruiting

500 enrolled

Breast

Breast Neoplasms

NCT05386108 2026-04-06

ELECTRA

Phase 1/2 Recruiting

73 enrolled

BreastCNS

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

Clinical Trials

EvoPAR-BR01

CYCAD-1

ELAINEIII

ELECTRA

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

INX-315-01

CAROLEEN

Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer

PIKASSO-01

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Morpheus-panBC

CAPItello-292

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

FourLight-3

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Next MONARCH 1

MONARCH plus

MONARCH 3

SERENA-1

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

SERENA-6

postMONARCH

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

ELEVATE

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

AMEERA-1

Study of AVZO-021 in Patients With Advanced Solid Tumors

MORPHEUS HR+BC

MONARCH 2

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

eMonarcHER

EMBER-3

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

CAMBRIA-2

EMBER

First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

monarchE

ELAINEII

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

monarcHER

PACT

A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer

VERU-024

A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer

A Study of LY3023414 in Participants With Advanced Cancer